Berman Capital Advisors, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$9,000
+80.0%
55
+19.6%
0.00%0.0%
Q2 2021$5,000
-16.7%
46
-2.1%
0.00%0.0%
Q1 2021$6,000
+20.0%
47
+2.2%
0.00%0.0%
Q4 2020$5,0000.0%460.0%0.00%0.0%
Q3 2020$5,000
+66.7%
46
+35.3%
0.00%0.0%
Q2 2020$3,0000.0%340.0%0.00%0.0%
Q1 2020$3,000340.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders